Clinical Trials on Prosthetic Treatment in Singapore
Total 53 results
-
KK Women's and Children's HospitalCompletedInfertility | Poor Responder to IVF TreatmentSingapore
-
National University Hospital, SingaporeUnknownFocus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.Singapore
-
KK Women's and Children's HospitalRecruitingEndometrial Hyperplasia | Fertility Issues | Treatment Side Effects | Disease RegressionSingapore
-
Tan Tock Seng HospitalProsfit Technologies JSC; Centre for Allied Health and Pharmacy Excellence...CompletedAmputation | Prosthesis UserSingapore
-
Tychan Pte Ltd.Duke-NUS Graduate Medical School; Singapore Clinical Research InstituteWithdrawnTreatment of Acute Zika Virus InfectionSingapore
-
Tychan Pte Ltd.National University Hospital, Singapore; National University, Singapore; Duke-NUS... and other collaboratorsCompletedTreatment of Acute Zika Virus InfectionSingapore
-
National Dental Centre, SingaporeSinghealth FoundationCompletedDental Prosthesis FailureSingapore
-
Singapore General HospitalCompletedBenign Prostatic HyperplasiaSingapore
-
Singapore General HospitalActive, not recruiting
-
National Cancer Centre, SingaporeUnknown
-
National Cancer Centre, SingaporeUnknownProstate CancerSingapore
-
Tysana Pte LtdCompletedTreatment of Acute Yellow Fever Virus InfectionSingapore
-
Singapore General HospitalCompletedCancer of the ProstateSingapore
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
ProstaCare Singapore Pte. Ltd.TerminatedBenign Prostatic HyperplasiaSingapore, New Zealand
-
PfizerCompletedUrinary Bladder, Overactive | Prostatic Hyperplasia | Erectile DysfunctionSingapore
-
National University Hospital, SingaporeNational University of SingaporeActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Hormone Sensitive Prostate CancerSingapore
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeRecruitingBlood Vessel Prosthesis | Arteriovenous Shunt ThrombosisSingapore
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
AO Clinical Investigation and Publishing DocumentationCompletedDistal Radius Fractures | Poor Bone Quality | Treatment ComplicationsUnited States, Singapore, Switzerland, Austria, Germany, Italy
-
BayerCompletedProstatic NeoplasmsChina, Singapore, Taiwan, Korea, Republic of
-
Novartis PharmaceuticalsRecruitingProstatic NeoplasmKorea, Republic of, Singapore, United States, Canada, Poland, Spain, Czechia
-
Astellas Pharma Singapore Pte. Ltd.CompletedProstate CancerHong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
Boehringer IngelheimCompletedProstatic Neoplasms, Castration-ResistantKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Singapore, Hong Kong, Netherlands
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
Janssen Research & Development, LLCCompletedProstatic NeoplasmsChina, Taiwan, India, Malaysia, Japan, Korea, Republic of, Singapore, Thailand
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
SanofiCompletedNeoplasms | Prostatic NeoplasmsUnited States, Argentina, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Russian Federation, Singapore, Slovakia, South Africa, Spain and more
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
SanofiRegeneron PharmaceuticalsCompletedProstatic Neoplasms | Neoplasm MetastasisUnited States, France, Canada, Brazil, Russian Federation, Ukraine, Australia, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Estonia, Singapore, Taiwan, Belgium, Czech Republic, Argentina, Denmark, Hungary, Israel, Italy, United Kingdom and more
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Poland, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
BayerActive, not recruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Spain, Korea, Republic of, United Kingdom, Australia, Hong Kong, Singapore, Taiwan, Lithuania, Russian Federation, Turkey, France, Israel, Czechia, Italy, Germany, Finland, Austria, Poland, Hungary
-
Johnson & Johnson Pharmaceutical Research & Development...Approved for marketingUrogenital Neoplasms | Genital Neoplasms, Male | Prostate Neoplasms | Genital Diseases, MaleUnited States, Australia, Hong Kong, Spain, Colombia, Mexico, Poland, Malaysia, Romania, Canada, Greece, Taiwan, Korea, Republic of, New Zealand, Singapore, Brazil, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary and more
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, Hong Kong, Portugal, Romania, Chile, Czechia, France, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
BayerJanssen Research & Development, LLCCompletedProstatic NeoplasmsBelgium, Spain, Canada, United States, Japan, Russian Federation, France, Finland, Singapore, Australia, Germany, Israel, Netherlands, Norway, Italy, United Kingdom, Poland, Sweden, Brazil
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Novartis PharmaceuticalsAlliance Foundation Trials, LLC.; RTOG Foundation, Inc.Active, not recruitingProstatic NeoplasmsUnited States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
-
Bristol-Myers SquibbActive, not recruitingProstate CancerRomania, United States, Israel, Russian Federation, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Puerto Rico, Singapor... and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada, Israel, Hong Kong, Singapore, Switzerland